While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...

CVS Health将2025年全年利润预期从之前的每股6.00美元至6.20美元，上调至每股6.30美元至6.40美元，而LSEG的分析师平均预期为每股6.12美元。该公司将利润预期上调归因于其二季度的业绩。

Investing.com - CVS再次上调了其全年利润预测，该集团表示这得益于其医疗保健福利以及药房和消费者健康部门的强劲表现。 在10月接任公司掌舵人的首席执行官David ...

智通财经APP获悉，西维斯健康 (CVS.US)周四公布的第二季度利润和营收均超市场预期，并上调了全年调整后利润指引，这主要得益于其零售药房业务的强劲表现和保险业务的改善。受此提振，这家连锁药房巨头股价盘前一度大涨逾9%。

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is ...

Investing.com - CVS has once again raised its full-year profit forecast, as the conglomerate said it was boosted by strength ...

For full-year 2025, the insurer raised its profit outlook to $6.30 to $6.40 per share, compared with an average analyst ...

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

CVS Health beat Wall Street estimates for second-quarter profit on Thursday, as tight oversight of higher medical costs led ...

CVS beats Q2 earnings and revenue estimates, lifts full-year forecast. Stock surges over 8% in premarket trading, up 39% YTD.

CVS beat Wall Street estimates in its second quarter earnings Thursday, bringing relief to a stock under pressure from higher ...

CVS Health Corp. raised its profit guidance for the year after posting strong results in its health insurance and pharmacy ...